|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 400.12 USD | -3.00% |
|
+6.90% | +8.46% |
| 05-21 | Baird Adjusts Price Target on Elevance Health to $492 From $529, Maintains Neutral Rating | MT |
| 05-16 | The latest transactions by star managers |  |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last hours
Enjoy this offer
* See conditions on site
| Capitalization | 90.4B 79.72B 74.61B 67.25B 125B 7,737B 140B 864B 338B 3,508B 339B 332B 12,989B | P/E ratio 2025 * |
13.1x | P/E ratio 2026 * | 10.8x |
|---|---|---|---|---|---|
| Enterprise value | 111B 97.69B 91.42B 82.41B 153B 9,481B 171B 1,059B 414B 4,299B 415B 407B 15,916B | EV / Sales 2025 * |
0.57x | EV / Sales 2026 * | 0.53x |
| Free-Float |
99.81% | Yield 2025 * |
1.71% | Yield 2026 * | 1.83% |
More valuation ratios
* Estimated data
More news
Last Transcript: Elevance Health, Inc.
More recommendations
More press releases
| 1 day | -0.12% | ||
| 1 week | +6.90% | ||
| Current month | -4.86% | ||
| 1 month | -1.62% | ||
| 3 months | +3.90% | ||
| 6 months | -0.86% | ||
| Current year | +8.46% |
| 1 week | 390.12 |  | 412.96 |
| 1 month | 357.45 | | 432.93 |
| Current year | 357.45 | | 458.75 |
| 1 year | 357.45 | | 567.26 |
| 3 years | 357.45 | | 567.26 |
| 5 years | 244.1 | | 567.26 |
| 10 years | 114.85 | | 567.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 64 | 19/11/2017 |
Mark Kaye
DFI | Director of Finance/CFO | 46 | 31/10/2023 |
Dustin Wilcox
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Ramiro Peru
BRD | Director/Board Member | 69 | 29/11/2004 |
Robert Dixon
BRD | Director/Board Member | 69 | 30/06/2011 |
Lewis Hay
BRD | Director/Board Member | 69 | 30/06/2013 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 3.22% | 21 M€ | -1.11% | - | |
| 2.07% | 6 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.00% | +6.90% | -26.67% | -18.82% | 93.2B | ||
| -5.78% | -1.63% | -42.13% | -37.62% | 292B | ||
| -2.43% | +4.53% | -5.73% | +22.20% | 86.82B | ||
| -1.97% | +2.14% | -22.53% | -28.51% | 30.83B | ||
| -3.74% | +6.64% | -30.89% | -44.09% | 30.81B | ||
| -2.00% | +2.57% | -6.63% | +3.26% | 17.68B | ||
| -2.23% | +2.82% | +105.77% | +54.07% | 3.1B | ||
| -3.11% | -3.06% | -22.83% | -39.77% | 1.87B | ||
| -4.61% | +6.34% | +279.64% | +28.47% | 1.87B | ||
| -1.24% | +0.29% | -3.36% | - | 395M | ||
| Average | -2.42% | +3.83% | +22.46% | -6.76% | 55.83B | |
| Weighted average by Cap. | -2.51% | +4.94% | -29.07% | -23.01% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 194B 171B 160B 144B 268B 16,611B 300B 1,856B 726B 7,532B 728B 713B 27,884B | 208B 184B 172B 155B 288B 17,826B 322B 1,991B 779B 8,083B 781B 765B 29,925B |
| Net income | 6.9B 6.09B 5.7B 5.14B 9.55B 591B 10.68B 66.01B 25.82B 268B 25.89B 25.36B 992B | 8.17B 7.21B 6.74B 6.08B 11.3B 699B 12.64B 78.12B 30.56B 317B 30.65B 30.01B 1,174B |
| Net Debt | 20.37B 17.97B 16.82B 15.16B 28.18B 1,744B 31.52B 195B 76.19B 791B 76.42B 74.84B 2,927B | 19.05B 16.8B 15.72B 14.17B 26.34B 1,630B 29.47B 182B 71.23B 739B 71.45B 69.97B 2,737B |
More financial data
* Estimated data
Employees
104,200
Sector
Managed Healthcare
Calendar
06-09
- Détachement de
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/05/25 | 400.12 $ | -3.00% | 1,540,107 |
| 20/05/25 | 412.49 $ | +2.15% | 1,221,238 |
| 19/05/25 | 403.81 $ | +0.13% | 1,329,566 |
| 16/05/25 | 403.29 $ | +3.41% | 2,542,818 |
| 15/05/25 | 390.00 $ | +4.20% | 2,954,406 |
Delayed Quote Nyse, May 21, 2025 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
400.12USD
Average target price
505.44USD
Spread / Average Target
+26.32%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ELV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition